US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Defiance Leveraged Long + Income HIMS ETF

5.43

0.0000

Volume:- -

Turnover:- -

Market Cap:2.71M

PE:- -

High:5.43

Open:5.43

Low:5.43

Close:5.43

52wk High:28.09

52wk Low:4.63

Shares:500.00K

Float Shares:500.00K

Volume Ratio:- -

T/O Rate:- -

Dividend:5.56

Dividend Rate:102.40%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company

THOMSON REUTERS

Cboe data shows mixed options sentiment in Hims and Hers Health with shares down 9.35%

Press Release: Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026

Hims & Hers Sets Second-quarter Results Release and Investor Call

Hims & Hers's Peptide Opportunity Remains in Focus

Hims & Hers Health is Maintained at Neutral by B of a Securities

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS) and Tarsus Pharmaceuticals (TARS)

Hims & Hers CFO Oluyemi Okupe Disposes of 7,163 Common Shares for $261,540.56

Trump's FDA May Soon Throw Its Weight Behind Peptides. Should You Buy In?

Hims & Hers Health (HIMS) Secures $400 Million Financing, Is The Upside Already Priced In?

Simply Wall St.

Hims & Hers Health - Receivables Purchase Agreement Has Initial 364-day Term, Extendable by Written Agreement - SEC Filing

THOMSON REUTERS

Hims & Hers Signs USD 400 Million Receivables Purchase Facility with Jpmorgan Chase

Sector Update: Healthcare

MT Newswires Live

BofA Securities Adjusts Hims & Hers Health Price Target to $36 From $25, Maintains Neutral Rating

MT Newswires Live

Hims & Hers Health is Maintained at Neutral by B of a Securities

HIMS Stock Jumps after Canaccord Raises Price Target to Street-High of $40

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Oruka Therapeutics (ORKA) and Hims & Hers Health (HIMS)

Hims & Hers : Bofa Global Research Raises Price Objective to $36.00 from $25.00

THOMSON REUTERS

Moderately bullish activity in Hims and Hers Health with shares up 5.3%

Analysis-hims' Obesity Drug Business May Get Boost as Employers Drop Coverage

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/HIMY/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HIMY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HIMY\",,,,,undefined,":{"symbol":"HIMY","market":"US","secType":"STK","nameCN":"Defiance Leveraged Long + Income HIMS ETF","latestPrice":5.4272,"timestamp":1788206400000,"preClose":5.4272,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":500000,"shares":500000,"eps":0,"marketStatus":"Post-Mkt","change":0,"latestTime":"08-31 16:42:15 EDT","open":5.4272,"high":5.4272,"low":5.4272,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788220800000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":5.4272,"sharesOutstanding":450000,"nav":5.39,"aum":2430000,"dividendRate":1.024009,"bidAskSpread":0,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HIMY\",,,,,undefined,":{"symbol":"HIMY","floatShares":500000,"roa":"--","roe":"--","lyrEps":0,"shares":500000,"dividePrice":5.5575,"high":5.4272,"amplitude":0,"preClose":5.4272,"low":5.4272,"week52Low":4.6299,"pbRate":"--","week52High":28.0918,"institutionHeld":0,"latestPrice":5.4272,"eps":0,"divideRate":1.024009,"volume":0,"delay":0,"ttmEps":0,"open":5.4272,"prevYearClose":6.5028,"prevWeekClose":5.4272,"prevMonthClose":5.4272,"prevQuarterClose":5.4272,"fiveDayClose":5.4272,"twentyDayClose":5.4272,"sixtyDayClose":5.4272},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HIMY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-01-27","symbol":"HIMY","reason":null,"defaultRemindTime":1769524200000,"announcedDate":"2026-01-26","type":"delisting","dateTimestamp":1769490000000},{"date":"2026-01-21","symbol":"HIMY","amount":0.0727,"announcedDate":"2026-01-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-01-21","defaultRemindTime":1769005800000,"name":"Defiance Leveraged Long + Income HIMS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-22","payableDate":"2026-01-21","currency":"USD","dateTimestamp":1768971600000,"payDate":"2026-01-22"},{"date":"2026-01-14","symbol":"HIMY","amount":0.0725,"announcedDate":"2026-01-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-01-14","defaultRemindTime":1768401000000,"name":"Defiance Leveraged Long + Income HIMS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-15","payableDate":"2026-01-14","currency":"USD","dateTimestamp":1768366800000,"payDate":"2026-01-15"},{"date":"2026-01-07","symbol":"HIMY","amount":0.1045,"announcedDate":"2026-01-06","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-01-07","defaultRemindTime":1767796200000,"name":"Defiance Leveraged Long + Income HIMS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-08","payableDate":"2026-01-07","currency":"USD","dateTimestamp":1767762000000,"payDate":"2026-01-08"},{"date":"2025-12-31","symbol":"HIMY","amount":0.1087,"announcedDate":"2025-12-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-31","defaultRemindTime":1767191400000,"name":"Defiance Leveraged Long + Income HIMS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-02","payableDate":"2025-12-31","currency":"USD","dateTimestamp":1767157200000,"payDate":"2026-01-02"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HIMY\",market:\"US\",,,undefined,":[{"executeDate":"2025-09-03","recordDate":"2025-09-03","paymentDate":"2025-09-04","value":0.2607,"currency":"USD"},{"executeDate":"2025-09-10","recordDate":"2025-09-10","paymentDate":"2025-09-11","value":0.3316,"currency":"USD"},{"executeDate":"2025-09-17","recordDate":"2025-09-17","paymentDate":"2025-09-18","value":0.3517,"currency":"USD"},{"executeDate":"2025-09-24","recordDate":"2025-09-24","paymentDate":"2025-09-25","value":0.5051,"currency":"USD"},{"executeDate":"2025-10-01","recordDate":"2025-10-01","paymentDate":"2025-10-02","value":0.5127,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HIMY\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HIMY\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2652128076","title":"Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2652128076","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652128076?lang=en_us&edition=fundamental","pubTime":"2026-07-18 04:17","pubTimestamp":1784319420,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nTUA3QRRTB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HMYY","BK4196","HIMY","HIYY","THNR","HEAL","HIMS","HIMZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652424679","title":"Cboe data shows mixed options sentiment in Hims and Hers Health with shares down 9.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652424679","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652424679?lang=en_us&edition=fundamental","pubTime":"2026-07-17 03:55","pubTimestamp":1784231711,"startTime":"0","endTime":"0","summary":"Cboe data shows mixed options sentiment in Hims and Hers Health (HIMS), with shares down $3.48 near $33.70. Options volume roughly in line with ave...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-hims-and-hers-health-with-shares-down-9-35-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-hims-and-hers-health-with-shares-down-9-35-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIMS","HIMY","THNR","HIMZ","HMYY","HEAL","HIYY","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651614124","title":"Press Release: Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2651614124","media":"Dow Jones","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651614124?lang=en_us&edition=fundamental","pubTime":"2026-07-14 04:23","pubTimestamp":1783974180,"startTime":"0","endTime":"0","summary":"SAN FRANCISCO--(BUSINESS WIRE)--July 13, 2026--Hims & Hers Health, Inc. (\"Hims & Hers\", NYSE: HIMS), the leading health and wellness platform, today announced that it will report second quarter 2026 f","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMY","HMYY","HIMS","HIYY","BK4196","THNR","HIMZ","HEAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651419401","title":"Hims & Hers Sets Second-quarter Results Release and Investor Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2651419401","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651419401?lang=en_us&edition=fundamental","pubTime":"2026-07-14 04:05","pubTimestamp":1783973156,"startTime":"0","endTime":"0","summary":"Hims & Hers sets second-quarter results release and investor callHims & Hers schedules second-quarter 2026 results for Aug. 10, 2026.Conference call set for Aug. 10, 2026 at 5 p.m. ET, following the m","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nNDL8fblfc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEAL","HMYY","HIMZ","HIYY","HIMY","THNR","HIMS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650755249","title":"Hims & Hers's Peptide Opportunity Remains in Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2650755249","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650755249?lang=en_us&edition=fundamental","pubTime":"2026-07-10 00:14","pubTimestamp":1783613640,"startTime":"0","endTime":"0","summary":"1214 ET - Hims & Hers Health is likely to beat estimates and raise its full-year guidance when it reports second-quarter results, but its potential opportunity in peptides is the biggest thing on investors' minds, Truist Securities analysts say in a note. The analysts point to credit-card data from June, which shows strong trends in the telehealth company's GLP-1 business as the rest of its business remains stable, they say. However, the stock has gained lately due to enthusiasm around the company's potential in peptides, making for a tough risk-reward setup for shares heading into the Food and Drug Administration's advisory committee meeting later this month, which will consider several peptides, the analysts say. Even if the committee gives a favorable recommendation, Hims likely wouldn't see any meaningful revenue boost from a potential peptide offering before 2028, the analysts say.  Dow Jones NewswiresJuly 09, 2026 12:14 ET Copyright  2026 Dow Jones & Company, Inc.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMZ","THNR","HEAL","HMYY","HIMS","HIYY","BK4196","HIMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650296659","title":"Hims & Hers Health is Maintained at Neutral by B of a Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2650296659","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650296659?lang=en_us&edition=fundamental","pubTime":"2026-07-09 19:38","pubTimestamp":1783597080,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HIMS/analyst-ratings(END) Dow Jones NewswiresJuly 09, 2026 07:38 ET","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEAL","HMYY","THNR","HIMZ","BK4196","HIMS","HIYY","HIMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650923855","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS) and Tarsus Pharmaceuticals (TARS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650923855","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650923855?lang=en_us&edition=fundamental","pubTime":"2026-07-09 17:50","pubTimestamp":1783590627,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Hims & Hers Health (HIMS) and Tarsus Pharmaceutica...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-hims-hers-health-hims-and-tarsus-pharmaceuticals-tars-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-hims-hers-health-hims-and-tarsus-pharmaceuticals-tars-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIYY","HIMS","HEAL","TARS","HMYY","HIMZ","BK4007","THNR","BK4196","HIMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649865930","title":"Hims & Hers CFO Oluyemi Okupe Disposes of 7,163 Common Shares for $261,540.56","url":"https://stock-news.laohu8.com/highlight/detail?id=2649865930","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649865930?lang=en_us&edition=fundamental","pubTime":"2026-07-08 04:21","pubTimestamp":1783455682,"startTime":"0","endTime":"0","summary":"Hims & Hers CFO Oluyemi Okupe disposes of 7,163 common shares for $261,540.56Hims & Hers CFO Oluyemi Okupe sold 7,163 Class A shares at an average price of $36.49 on July 6, 2026.The sale followed the","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDL9VLQww:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hims & Hers CFO Oluyemi Okupe Disposes of 7,163 Common Shares for $261,540.56","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMZ","BK4196","HIYY","THNR","HIMS","HMYY","HIMY","HEAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649690202","title":"Trump's FDA May Soon Throw Its Weight Behind Peptides. Should You Buy In?","url":"https://stock-news.laohu8.com/highlight/detail?id=2649690202","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649690202?lang=en_us&edition=fundamental","pubTime":"2026-07-05 14:00","pubTimestamp":1783231200,"startTime":"0","endTime":"0","summary":"Many Americans would love a drug that makes them fitter, sharper, and more attractive. The peptides industry aims to oblige, and sales may soon be off to the races, courtesy of the Trump Administratio","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIYY","BK4196","HIMS","THNR","BK4007","BK4585","BK4588","NVOH","HIMY","HMYY","LU1093756325.SGD","NVO","NVOX","LU1093756168.USD","LU0154236417.USD","IE00BKVL7J92.USD","BK4532","IE00BZ1G4Q59.USD","OZEM","HIMZ","HEAL","PPH","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648503293","title":"Hims & Hers Health (HIMS) Secures $400 Million Financing, Is The Upside Already Priced In?","url":"https://stock-news.laohu8.com/highlight/detail?id=2648503293","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648503293?lang=en_us&edition=fundamental","pubTime":"2026-07-02 14:41","pubTimestamp":1782974499,"startTime":"0","endTime":"0","summary":"Hims & Hers Health (HIMS) is back in focus after securing a $400 million financing arrangement with JPMorgan Chase Bank. This move improves liquidity while regulatory scrutiny of its peptide ambitions intensifies.\nSee our latest analysis for Hims & Hers Health.\nAt a share price of $37.57, Hims & Hers Health has seen strong short term momentum, with a 1 month share price return of 35.34% and 90 day share price return of 96.29%, while the 1 year total shareholder return declined 20.84% but the...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/hims-hers-health-hims-secures-400-million-financing-is-the-u","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/hims-hers-health-hims-secures-400-million-financing-is-the-u","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HIMZ","HIMY","HIYY","HMYY","BK4196","HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648256529","title":"Hims & Hers Health - Receivables Purchase Agreement Has Initial 364-day Term, Extendable by Written Agreement - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2648256529","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648256529?lang=en_us&edition=fundamental","pubTime":"2026-07-02 05:03","pubTimestamp":1782939813,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nFWN433146:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIYY","HMYY","BK4196","HIMS","HIMY","HIMZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648529254","title":"Hims & Hers Signs USD 400 Million Receivables Purchase Facility with Jpmorgan Chase","url":"https://stock-news.laohu8.com/highlight/detail?id=2648529254","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648529254?lang=en_us&edition=fundamental","pubTime":"2026-07-02 05:03","pubTimestamp":1782939803,"startTime":"0","endTime":"0","summary":"Hims & Hers signs USD 400 million receivables purchase facility with JPMorgan ChaseHims & Hers subsidiaries XeCare, Apostrophe Pharmacy entered a Master Receivables Purchase Agreement with JPMorgan on","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nNDL96VZhv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2023250330.USD","LU0106831901.USD","IE00BLSP4239.USD","IE00BHPRN162.USD","LU1116320737.USD","LU1244550577.SGD","LU0943347566.SGD","LU0964807845.USD","LU1162221912.USD","LU0070302665.USD","LU2054465674.USD","LU0234572021.USD","LU2023250504.SGD","LU1670628061.USD","LU2237443465.HKD","LU0203345920.USD","IE00BWXC8680.SGD","HIYY","LU0006306889.USD","IE00BDCRKT87.USD","LU2106854487.HKD","LU2756315318.SGD","LU0215105999.USD","LU1670627923.USD","IE00BLSP4452.SGD","IE0034235303.USD","LU1267930490.SGD","LU1548497426.USD","IE00BFXG1179.USD","LU0345769631.USD","LU1720051017.SGD","LU2456880835.USD","LU0320765646.SGD","BK4533","LU0820561818.USD","LU0820561909.HKD","IE00B1BXHZ80.USD","BK4534","IE00BBT3K403.USD","LU1064131342.USD","LU0256863902.USD","IE00BKDWB100.SGD","LU1363072403.SGD","LU2462157665.USD","LU0265550946.USD","IE00B1XK9C88.USD","LU0211331839.USD","LU0976567544.SGD","SG9999002232.USD","IE00BJLML261.HKD","LU0267386448.USD","LU2357627491.SGD","LU0187121727.USD","LU1244550494.USD","LU2236285917.USD","LU0208291251.USD","LU0689472784.USD","HIMS","IE00BDRTCR15.USD","LU1720051108.HKD","LU0868494617.USD","LU1032466523.USD","LU2430703178.SGD","LU1119994496.HKD","LU2552382058.USD","LU2592432038.USD","BK4207","LU1917777945.USD","LU0417517546.SGD","LU2023250843.SGD","LU2357305700.SGD","LU0211328371.USD","JPM","LU1668664300.SGD","HIMY","LU1988902786.USD","LU2505996681.GBP","IE00BN8TJ469.HKD","IE00BJTD4V19.USD","HMYY","LU0942090050.USD","LU2505996509.AUD","IE00B775SV38.USD","LU2237443978.SGD","LU0265550359.USD","LU1496350502.SGD","JPO","LU0256863811.USD","BK4581","LU1551013342.USD","LU2237443549.SGD","IE0034235295.USD","SG9999002224.SGD","LU0859254822.USD","LU2237443382.USD","LU2264538146.SGD","LU2552382215.SGD","IE00BYXW3230.USD","IE00BJTD4N35.SGD","LU0211326839.USD","IE0034235188.USD","LU0170899867.USD","LU1894683348.USD","LU1914381329.SGD","LU0345770308.USD","LU2756315664.SGD","LU0234570918.USD","LU2242649171.HKD","LU1280957306.USD","LU0238689110.USD","LU1084165304.USD","LU2430703251.USD","LU0106261372.USD","JPX","LU1629891620.HKD","LU0882574139.USD","LU2213496289.HKD","LU2237443895.HKD","LU1551013425.SGD","LU2381873111.SGD","LU0323591593.USD","BK4588","LU0640476718.USD","LU0971096721.USD","LU1244550221.USD","LU0211326755.USD","LU1261432733.SGD","LU2237443622.USD","LU2430703095.HKD","IE000M9KFDE8.USD","LU0320765489.SGD","LU1366192091.USD","IE00BKVL7J92.USD","LU0683600562.USD","BK4566","LU2417539215.USD","BK4516","LU0345770993.USD","IE00BZ1G4Q59.USD","LU1496350171.SGD","BK4196","LU1145028129.USD","LU0868494708.USD","LU0345769128.USD","LU1116320901.HKD","BK4550","JPMO","LU2244417387.USD","LU0310799852.SGD","LU2211815571.USD","LU0820562030.AUD","LU0787776722.HKD","BK4585","LU0251132253.USD","LU2746668974.SGD","LU0203347892.USD","BK4504","LU1974910355.USD","LU2552382132.HKD","LU0149725797.USD","LU2746668461.USD","LU0048584097.USD","LU0211327993.USD","LU0496365809.HKD","LU1894683264.USD","IE00B3S45H60.SGD","HIMZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648540507","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2648540507","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648540507?lang=en_us&edition=fundamental","pubTime":"2026-07-02 01:19","pubTimestamp":1782926397,"startTime":"0","endTime":"0","summary":"Healthcare stocks rose Wednesday afternoon, with the NYSE Healthcare Index increasing 0.1% and the State Street Health Care Select Sector SPDR ETF  adding 0.4%.The iShares Biotechnology ETF  was fractionally higher.In corporate news, Hims & Hers Health  shares jumped past 8% after BofA Securities lifted the company's price target to $36 from $25, while keeping its neutral rating.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","XLV","XBI","BK4585","HIMS","HMYY","HIMY","LU0029874061.USD","BK4196","BK4581","BK4137","HIYY","LU0128526141.USD","HIMZ","HCSG","IBB","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648940549","title":"BofA Securities Adjusts Hims & Hers Health Price Target to $36 From $25, Maintains Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2648940549","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648940549?lang=en_us&edition=fundamental","pubTime":"2026-07-01 22:06","pubTimestamp":1782914817,"startTime":"0","endTime":"0","summary":"Hims & Hers Health (HIMS) has an average rating of Hold and mean price target of $29.27, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HMYY","HIYY","HIMZ","HIMS","HIMY","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648543734","title":"Hims & Hers Health is Maintained at Neutral by B of a Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2648543734","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648543734?lang=en_us&edition=fundamental","pubTime":"2026-07-01 20:52","pubTimestamp":1782910320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HIMS/analyst-ratings(END) Dow Jones NewswiresJuly 01, 2026 08:52 ET","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HMYY","HIMZ","BK4196","HIMS","HIMY","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648154824","title":"HIMS Stock Jumps after Canaccord Raises Price Target to Street-High of $40","url":"https://stock-news.laohu8.com/highlight/detail?id=2648154824","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648154824?lang=en_us&edition=fundamental","pubTime":"2026-07-01 20:16","pubTimestamp":1782908218,"startTime":"0","endTime":"0","summary":"Shares of Hims & Hers ($HIMS) rose in pre-market trading after receiving a new Street-high price target of $40. Canaccord Genuity analyst Maria Rip...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/hims-stock-jumps-after-canaccord-raises-price-target-to-street-high-of-40?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/hims-stock-jumps-after-canaccord-raises-price-target-to-street-high-of-40?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIMY","HIMZ","HIMS","BK4196","HMYY","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648510005","title":"Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Oruka Therapeutics (ORKA) and Hims & Hers Health (HIMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2648510005","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648510005?lang=en_us&edition=fundamental","pubTime":"2026-07-01 20:01","pubTimestamp":1782907265,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGN), Oruka Therapeutics (ORKA) and Hims &...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-oruka-therapeutics-orka-and-hims-hers-health-hims-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-oruka-therapeutics-orka-and-hims-hers-health-hims-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","LU2242646821.SGD","LU0320765992.SGD","LU2468319806.SGD","04332","BK4566","LU0289739699.SGD","BK4581","BK4533","HIMY","BK4599","IE0002141913.USD","IE0009355771.USD","LU1571399168.USD","LU0122379950.USD","LU0109394709.USD","SG9999001440.SGD","LU1061106388.HKD","ORKA","LU0889565916.HKD","IE00B4R5TH58.HKD","AMGN","BK4585","LU2089984988.USD","BK4534","BK4139","LU1057294990.SGD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","HMYY","HIMS","LU1983299246.USD","LU2242652126.USD","LU1023059063.AUD","BK4588","IE00B2B36J28.USD","LU0058720904.USD","HIMZ","LU2112291526.USD","IE00BJT1NW94.SGD","HIYY","LU0868494617.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648517550","title":"Hims & Hers : Bofa Global Research Raises Price Objective to $36.00 from $25.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2648517550","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648517550?lang=en_us&edition=fundamental","pubTime":"2026-07-01 19:05","pubTimestamp":1782903937,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nAZN4T5E2P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","HIMY","HMYY","HIMS","HIMZ","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646369411","title":"Moderately bullish activity in Hims and Hers Health with shares up 5.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646369411","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646369411?lang=en_us&edition=fundamental","pubTime":"2026-06-26 23:55","pubTimestamp":1782489309,"startTime":"0","endTime":"0","summary":"Moderately bullish activity in Hims and Hers Health (HIMS), with shares up $1.74, or 5.3%, near $34.45. Options volume running well above average w...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-hims-and-hers-health-with-shares-up-5-3-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-hims-and-hers-health-with-shares-up-5-3-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HMYY","HIYY","HIMZ","HIMS","HIMY","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646879143","title":"Analysis-hims' Obesity Drug Business May Get Boost as Employers Drop Coverage","url":"https://stock-news.laohu8.com/highlight/detail?id=2646879143","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646879143?lang=en_us&edition=fundamental","pubTime":"2026-06-25 18:00","pubTimestamp":1782381600,"startTime":"0","endTime":"0","summary":"CORRECTED-ANALYSIS-Hims' obesity drug business may get boost as employers drop coverageCorrects paragraph 15 to reflect that Hims & Hers is one of the most volume-producing of Novo’s partners, and not","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nL1N42O14W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HMYY","TFC","HIMY","LU0058720904.USD","CI","IE00B19Z3581.USD","LU1059921491.USD","BK4190","HIMS","IE00BSNM7G36.USD","LU1261432733.SGD","BK4585","ESCA","BK4588","LU0289739699.SGD","HIYY","HIMZ","LU2237438978.USD","BK4211","IE00B19Z3B42.SGD","LU0868494617.USD","BK4196","IE0002270589.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}